MX26142A - Derivados de acido benzoico para tratar enfermedades relacionadas con leucotrieno. - Google Patents

Derivados de acido benzoico para tratar enfermedades relacionadas con leucotrieno.

Info

Publication number
MX26142A
MX26142A MX2614291A MX2614291A MX26142A MX 26142 A MX26142 A MX 26142A MX 2614291 A MX2614291 A MX 2614291A MX 2614291 A MX2614291 A MX 2614291A MX 26142 A MX26142 A MX 26142A
Authority
MX
Mexico
Prior art keywords
leucotrene
derivatives
benzoic acid
diseases related
treat diseases
Prior art date
Application number
MX2614291A
Other languages
English (en)
Inventor
Robert A Daines
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MX26142A publication Critical patent/MX26142A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX2614291A 1990-06-07 1991-06-06 Derivados de acido benzoico para tratar enfermedades relacionadas con leucotrieno. MX26142A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53438890A 1990-06-07 1990-06-07

Publications (1)

Publication Number Publication Date
MX26142A true MX26142A (es) 1994-02-28

Family

ID=24129833

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2614291A MX26142A (es) 1990-06-07 1991-06-06 Derivados de acido benzoico para tratar enfermedades relacionadas con leucotrieno.

Country Status (16)

Country Link
EP (1) EP0532550A1 (es)
JP (1) JPH05507475A (es)
KR (1) KR930700445A (es)
CN (1) CN1058016A (es)
AU (1) AU7901791A (es)
CA (1) CA2083958A1 (es)
FI (1) FI925544A (es)
HU (1) HUT64748A (es)
IE (2) IE911913A1 (es)
IL (1) IL98388A0 (es)
MA (1) MA22196A1 (es)
MX (1) MX26142A (es)
PL (1) PL290586A1 (es)
PT (1) PT97912A (es)
WO (1) WO1991018880A1 (es)
ZA (1) ZA914323B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4226493A (en) * 1992-05-01 1993-11-29 Smithkline Beecham Corporation Leukotriene antagonists
WO1995015950A1 (en) * 1993-12-08 1995-06-15 Smithkline Beecham Corporation Compounds
IL106156A0 (en) * 1992-06-30 1993-10-20 Smithkline Beecham Corp Pyridinyl compounds
WO1994014442A1 (en) * 1992-12-23 1994-07-07 Smithkline Beecham Corporation Substituted pyridyl compounds useful as leukotriene antagonists
BR9507459A (pt) * 1994-04-13 1997-11-11 Hoffmann La Roche Antagonistas á base de piridino-leucotrieno b4 substituído
US7297357B2 (en) * 2001-03-27 2007-11-20 Meiji Seika Kaisha, Ltd. Process for producing puffed snack and production apparatus therefor
ES2622522T3 (es) 2003-08-26 2017-07-06 The Regents Of The University Of Colorado, A Body Corporate Inhibidores de la actividad proteasa de serina y su uso en métodos y composiciones para el tratamiento de infecciones bacterianas
US8093253B2 (en) 2008-03-06 2012-01-10 Hoffmann-La Roche Inc. Leukotriene B4 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4563446A (en) * 1983-07-27 1986-01-07 Takeda Chemical Industries, Ltd. Thromboxane synthetase inhibiting 3-(1-alkenyl) pyridines
GB8505285D0 (en) * 1985-03-01 1985-04-03 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
EP0532550A1 (en) 1993-03-24
FI925544A0 (fi) 1992-12-07
HUT64748A (en) 1994-02-28
CA2083958A1 (en) 1991-12-08
JPH05507475A (ja) 1993-10-28
AU7901791A (en) 1991-12-31
MA22196A1 (fr) 1992-04-01
ZA914323B (en) 1992-06-24
IE911912A1 (en) 1991-12-18
IE911913A1 (en) 1991-12-18
HU9203866D0 (en) 1993-03-29
FI925544A (fi) 1992-12-07
WO1991018880A1 (en) 1991-12-12
CN1058016A (zh) 1992-01-22
IL98388A0 (en) 1992-07-15
PT97912A (pt) 1992-03-31
PL290586A1 (en) 1992-04-06
KR930700445A (ko) 1993-03-15

Similar Documents

Publication Publication Date Title
AR240949A1 (es) Procedimiento para preparar derivados de acido n-(aminoalcanoil)-aza-biciclocarboxilico
MX9200216A (es) Procedimiento para la preparacion de anhidrido de acido malonico.
EE9500059A (et) Asendatud 4-fenüül-6-aminonikotiinhappe derivaatide kasutamine ravimitena
IT1150198B (it) Derivato di acido chinolincarbossilico
ES533495A0 (es) Procedimiento para la preparacion de derivados del acido oxamidico
MX9205435A (es) Derivados del acido imidazolil-propenico substituidos y procedimiento para su fabricacion.
MX164186B (es) Produccion de acido citrico
MX7101E (es) Procedimiento para la preparacion de derivados de acido quinolin-carboxilico
MX26167A (es) Derivados de acido piridil-benzoico para el tratamiento de enfermedades relacionadas con lecotrino.
AR230056A1 (es) Procedimiento para la preparacion de derivados del acido 3-ridilmetilo 3-piridilmetilo 3-inidazolilmetil indolil-acrilico
MX26142A (es) Derivados de acido benzoico para tratar enfermedades relacionadas con leucotrieno.
ES511489A0 (es) "procedimiento para preparar nuevos derivados de acidos fenil-alifatico-carboxilicos".
NO844462L (no) Bruk av ultraren hyaluronsyre for aa forbedre dyreleddfunksjoner
MX9205436A (es) Derivados del acido imidazolil-propenico y procedimiento para su fabricacion
ES535000A0 (es) Procedimiento para la preparacion de derivados de acido piridacinilcarboxilico
ES538029A0 (es) Procedimiento para la preparacion de derivados del acido indolacetico
ES508647A0 (es) Procedimiento de preparar derivados de acido carboxilico quetienen actividad antibacteriana.
BR9202293A (pt) Processo para preparacao de acido 5-hidroxipirazinocarboxilico
NO904184D0 (no) Anvendelse av alkylfosforsyreforbindelser for bekjempelseav psoriasis-sykdommer.
ES2014390A4 (es) Proceso para la fabricacion de mezclas de eteres acido carboxilicos
ES535896A0 (es) Procedimiento para preparar poliesteres de acido bencilidenmalonico
DE69305250T2 (de) Herstellung von Alkandicarbonsäurederivaten
MX9204109A (es) Derivados de acido 2-(imidazol-1-il)-2-bencil-etiliden-aminoxialcanoico y proceso para su preparacion.
ES491601A0 (es) Procedimiento para la preparacion de derivados de acido n-acil-amino
IT1162323B (it) Procedimento per la produzione di e steri di acido benzoico